November 29, 2017

What the FDA's New Framework Means for Regenerative Therapies

RARECast

The FDA recently passed a new policy framework governing the development and oversight of regenerative medicine. Attorney Michael Werner discussed these new policies and what they mean for the industry at large on an episode of RARECast.

Duration: 27:20

Related Insights

A Regulatory Assessment of AI Performance Guarantees

March 31, 2025

5 Minutes

Podcast - First 60 Days of the Trump Administration: Food and Agriculture Policy

March 28, 2025

U.S. Increases Tariffs on Vehicles and Automotive Parts

March 27, 2025

3 Minutes

Judicial Lifeline: Federal Court Temporarily Halts CFPB Changes

March 31, 2025

5 Minutes

Unpacking Trump Admin Plans for Value-Based Care

March 28, 2025

Bonds, Bankruptcies and Billion-Dollar Backlogs: Federal Offshore Decommissioning Liability

Spring 2025

Department of Energy Funding Update

March 28, 2025

5 Minutes

GSA MAS Contract Holders: Time May Be Running Short to Get Your House in Order

March 27, 2025

5 Minutes

Key Takeaways from President Trump's Executive Order to Strengthen U.S. Mineral Production

March 26, 2025

7 Minutes

What the FDA's New Framework Means for Regenerative Therapies

Related Professional

Related Practices

Related Industry

Related Insights

A Regulatory Assessment of AI Performance Guarantees

Judicial Lifeline: Federal Court Temporarily Halts CFPB Changes

Department of Energy Funding Update

Podcast - First 60 Days of the Trump Administration: Food and Agriculture Policy

Unpacking Trump Admin Plans for Value-Based Care

GSA MAS Contract Holders: Time May Be Running Short to Get Your House in Order

U.S. Increases Tariffs on Vehicles and Automotive Parts

Bonds, Bankruptcies and Billion-Dollar Backlogs: Federal Offshore Decommissioning Liability

Key Takeaways from President Trump's Executive Order to Strengthen U.S. Mineral Production